CTOs on the Move


 
Founded in 2004, BioRx is a national provider of specialty pharmacy, infusion management and industry consulting services. As a private, independently-owned company, BioRx is committed to a flexible service model that meets the needs of its customers, including consumers, healthcare providers, health plans and pharmaceutical manufacturers. The company’s streamlined management structure allows it to respond more quickly to changes in the marketplace and provide a higher level of service that is customized for each consumer. Moreover, BioRx helps to provide a more cost-effective level of healthcare – in particular by moving patients from costly facility-based infusion sites to their homes, thereby ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.biorx.com
  • 10828 Kenwood Rd
    Cincinnati, OH USA 45242
  • Phone: 866.442.4679

Executives

Name Title Contact Details

Similar Companies

Richland Public Health

Richland Public Health is the lead agency in the event of a county emergency of a biological nature, either through an infectious disease or terrorist threat.

Strand Life Sciences

Strand Life Sciences was founded in 2000 by four computer scientists with one objective: to apply the algorithms of computer coding to the life sciences. We leveraged this unique convergence of technology and biology expertise to develop a strong portfolio of products internationally that support research and diagnosis and treatment of disease. Today, our products are used in more than 2,000 scientific laboratories and 100 hospitals around the world.

M2 Communications

M2 Communications is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthnation

Healthnation, Inc. is a Lisle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monarch Medical Technologies

Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.